Drug intelligence / Profile preview

Unazin Cold

Development stage
Unknown
Lead developer
Fawn
Modality
Small Molecules
Administration
Oral
01

Overview

Unazin Cold is a multi-ingredient combination medication marketed by Fawn Incor for the symptomatic relief of the common cold, influenza, and associated upper respiratory tract symptoms. It is available in two primary formulations: an oral suspension and an oral tablet. The suspension formulation (Unazin Cold Suspension) is composed of paracetamol (acetaminophen) for pain and fever relief, phenylephrine hydrochloride as a nasal decongestant, chlorpheniramine maleate as an antihistamine to reduce allergic symptoms, sodium citrate as a mucolytic/expectorant, and menthol for its soothing local anesthetic properties. The tablet formulation contains paracetamol, phenylephrine, diphenhydramine, and caffeine. Together, these components work synergistically to alleviate nasal congestion, runny nose, sneezing, sore throat, headache, and fever.

Brand names
Unazin Cold
Other names
UNAZIN COLD SuspensionUnazin Cold Tablet
02

Targets

ADRA1A (α1A)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Unazin Cold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unazin Cold.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call